CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
Blood samplingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02790281
NCT02790281N/ACompleted
CompareCT.gov

A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

Ferring Pharmaceuticals·observational·Posted Jun 3, 2016·Updated Mar 6, 2017

In Brief

An observational study evaluating Blood sampling for Inflammatory Bowel Disease. Completed, enrolled 33 participants across 2 sites in 2 countries.

Detailed Summary

The purpose of this study is to measure IL-6 and IL-6/sIL-6R complex levels in subjects with active moderate to severe ulcerative colitis or Crohn's disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Bowel Disease
CountriesDenmark, Sweden
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 3, 2016
Enrollment StartDec 1, 2014
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.1 years ago

Interventions

Blood samplingprocedure

Blood sample collected at a single visit